Abstract:Background: Hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to be clinically effective, but the mechanisms by which hyperthermia enhances the sensitivity of cells to chemotherapeutic drugs has not yet been elucidated.Methods: To identify the key molecules involved in thermochemotherapy, this study used mass spectrometry (MS)-based quantitative proteomics technology to analyze the effects of thermochemotherapy on the heat-sensitive ovarian cancer cell line A2780. We divided the A2780 cell line into four groups, one group served as blank control, and the other three groups were stimulated by oxaliplatin, stimulated by hyperthermia at 42 ℃, and stimulated by hyperthermia combined with oxaliplatin. Samples were then collected for tandem mass tag (TMT) labeling, high-performance liquid chromatography fractionation, and MS-based quantitative proteomics for analysis The differentially expressed proteins were quantitatively compared and identified, and Gene Ontology (GO) assessment and cluster analyses were performed. Finally, the above MS results were verified again by Western blotting experiments.Results: A total of 349 differentially expressed proteins were identified between cells treated with chemotherapy alone (group B) and cells treated with a combination of chemotherapy and hyperthermia (group D). There were 145 upregulated proteins and 204 downregulated proteins. Among the top 20 proteins with significantly different expression levels, nearly two-thirds were involved in DNA damage repair. These proteins were subsequently verified by Western blot analysis. Indeed, consistent with MS data, the expression of the RBL1 protein was significantly upregulated in cells treated with thermochemotherapy (group D) compared to cells treated with chemotherapy alone (group B).Conclusions: In heat-sensitive ovarian cancer cells, the damage repair of tumor cell DNA is disturbed by hyperthermia, making it unable to fully repair when damaged by chemotherapeutic drugs. As a result, hyperthermia enhances the efficacy of chemotherapeutic drugs. <i>RBL1</i>, as a tumor suppressor gene, may be associated with the repair of DNA damage, and thus it may be a key target for hyperthermia to enhance the sensitivity of thermosensitive cells to chemotherapeutic drugs.

Hyperthermia Treatment and Cytokine

Progress of Hyperthermia in Tumor Treatment

Research progress on tumor hyperthermia

Progress in Anticancer Immunities by Hyperthermia

Hyperthermia Targeting the Tumor Microenvironment Facilitates Immune Checkpoint Inhibitors

Hyperthermia Combine with Other Therapies for Carcer Therapy

Progress of translational medicine in the tumor thermotherapy and tumor immunology

A Review of Hyperthermia Combined with Radiotherapy/chemotherapy on Malignant Tumors.

Harnessing Hyperthermia: Molecular, Cellular, and Immunological Insights for Enhanced Anticancer Therapies

Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors

Progress of Combination Therapy for Tumor Comprising Hyperthermia with Dendritic Cells

Recent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy

Hyperthermia and radiotherapy: physiological basis for a synergistic effect

Modulating the Heat Stress Response to Improve Hyperthermia-Based Anticancer Treatments

Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells

Molecular Imaging-Guided Interventional Hyperthermia in Treatment of Breast Cancer.

Differences of the Immune Phenotype of Breast Cancer Cells after Ex Vivo Hyperthermia by Warm-Water or Microwave Radiation in a Closed-Loop System Alone or in Combination with Radiotherapy

Enhanced Damage Effects Induced by Cell-Level Hyperthermia with Higher Heating Rate or Allied Cooling Procedure

THEORETICAL EVALUATION ON THE THERMAL EFFECTS OF EXTRACELLULAR HYPERTHERMIA AND INTRACELLULAR HYPERTHERMIA

Hyperthermia enhances the efficacy of chemotherapeutic drugs in heat-sensitive cells through interfering with DNA damage repair

Analysis of the Thermal Response and Requirement for Power Dissipation in Magnetic Hyperthermia with the Effect of Blood Temperature